Cold & Cough Remedies (Pharmacies) - Denmark

  • Denmark
  • Revenue in the Cold & Cough Remedies market is projected to reach US$2.71m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.52%, resulting in a market volume of US$3.36m by 2028.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.46 are generated in 2024.

Key regions: United Kingdom, South Korea, Europe, Japan, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Denmark has been experiencing steady growth in recent years.

Customer preferences:
In Denmark, customers have shown a growing preference for natural and herbal remedies for cold and cough. This shift towards natural products can be attributed to increasing health consciousness among consumers. Denmark has a strong culture of health and wellness, and consumers are actively seeking products that are perceived as more natural and less chemical-based. As a result, there has been a rise in demand for cold and cough remedies that are made from natural ingredients and have minimal side effects.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Denmark is the increasing popularity of over-the-counter (OTC) medications. OTC medications are easily accessible to consumers without the need for a prescription. This convenience factor has contributed to the growth of the market, as consumers can easily purchase cold and cough remedies from pharmacies without having to visit a doctor. The availability of a wide range of OTC medications in pharmacies has also contributed to the growth of the market, as consumers have more options to choose from. Another trend in the market is the growing demand for combination cold and cough remedies. These remedies are formulated to address multiple symptoms of cold and cough, such as congestion, sore throat, and coughing. Combination remedies offer convenience to consumers by providing relief from multiple symptoms with a single product. This trend is driven by the busy lifestyle of consumers, who prefer products that can provide quick and effective relief.

Local special circumstances:
Denmark has a well-developed healthcare system, with a strong emphasis on preventive care and self-medication. The Danish government encourages self-care and self-medication as a means to reduce the burden on the healthcare system. This has created a favorable environment for the growth of the Cold & Cough Remedies (Pharmacies) market, as consumers are encouraged to take responsibility for their own health and seek out remedies for common ailments like cold and cough.

Underlying macroeconomic factors:
The growing Cold & Cough Remedies (Pharmacies) market in Denmark can be attributed to several underlying macroeconomic factors. Firstly, Denmark has a high disposable income per capita, which allows consumers to spend more on healthcare products. Additionally, the aging population in Denmark is driving the demand for cold and cough remedies, as older individuals are more susceptible to respiratory illnesses. Finally, the increasing prevalence of cold and cough due to changing weather patterns and environmental factors is also contributing to the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Denmark is experiencing steady growth due to customer preferences for natural remedies, the popularity of OTC medications, and the demand for combination remedies. The local special circumstances of Denmark's healthcare system and the underlying macroeconomic factors of high disposable income, aging population, and changing weather patterns are also contributing to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)